Item 2.02-Results of Operations and Financial Condition

On March 17, 2021, Codiak BioSciences, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter and year ended December 31, 2020 and providing a business update. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information furnished under this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

Item 9.01-Financial Statements and Exhibits



(d) Exhibits



 Exhibit
 Number                                 Description

 99.1        Press release, dated March 17, 2021, by Codiak BioSciences, Inc.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses